294 related articles for article (PubMed ID: 38313016)
21. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.
Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M
Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161
[TBL] [Abstract][Full Text] [Related]
22. Unlocking the secrets: the power of methylation-based cfDNA detection of tissue damage in organ systems.
Zhang L; Li J
Clin Epigenetics; 2023 Oct; 15(1):168. PubMed ID: 37858233
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic Biomarkers in Cell-Free DNA and Applications in Liquid Biopsy.
Gai W; Sun K
Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30634483
[TBL] [Abstract][Full Text] [Related]
24. Prediction of methylation status using WGS data of plasma cfDNA for multi-cancer early detection (MCED).
Cui P; Zhou X; Xu S; He W; Huang G; Xiong Y; Zhang C; Chang T; Feng M; Lai H; Pan Y
Clin Epigenetics; 2024 Feb; 16(1):34. PubMed ID: 38414068
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic significance assessment of the circulating cell-free DNA in ovarian cancer: An updated meta-analysis.
Li B; Pu K; Ge L; Wu X
Gene; 2019 Sep; 714():143993. PubMed ID: 31330238
[TBL] [Abstract][Full Text] [Related]
26. Cell-free DNA methylation in the clinical management of lung cancer.
Ezegbogu M; Wilkinson E; Reid G; Rodger EJ; Brockway B; Russell-Camp T; Kumar R; Chatterjee A
Trends Mol Med; 2024 May; 30(5):499-515. PubMed ID: 38582623
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of commercial kits for isolation and bisulfite conversion of circulating cell-free tumor DNA from blood.
Kresse SH; Brandt-Winge S; Pharo H; Flatin BTB; Jeanmougin M; Vedeld HM; Lind GE
Clin Epigenetics; 2023 Sep; 15(1):151. PubMed ID: 37710283
[TBL] [Abstract][Full Text] [Related]
28. Genome-wide discovery and validation of diagnostic DNA methylation-based biomarkers for hepatocellular cancer detection in circulating cell free DNA.
Hlady RA; Zhao X; Pan X; Yang JD; Ahmed F; Antwi SO; Giama NH; Patel T; Roberts LR; Liu C; Robertson KD
Theranostics; 2019; 9(24):7239-7250. PubMed ID: 31695765
[TBL] [Abstract][Full Text] [Related]
29. Deep learning model integrating cfDNA methylation and fragment size profiles for lung cancer diagnosis.
Kim M; Park J; Seonghee Oh ; Jeong BH; Byun Y; Shin SH; Im Y; Cho JH; Cho EH
Sci Rep; 2024 Jun; 14(1):14797. PubMed ID: 38926407
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic Value of Circulating Free DNA Integrity and Global Methylation Status in Gall Bladder Carcinoma.
Kumari S; Husain N; Agarwal A; Neyaz A; Gupta S; Chaturvedi A; Lohani M; Sonkar AA
Pathol Oncol Res; 2019 Jul; 25(3):925-936. PubMed ID: 29376201
[TBL] [Abstract][Full Text] [Related]
31. Plasma cfDNA methylation markers for the detection and prognosis of ovarian cancer.
Liang L; Zhang Y; Li C; Liao Y; Wang G; Xu J; Li Y; Yuan G; Sun Y; Zhang R; Li X; Nian W; Zhao J; Zhang Y; Zhu X; Wen X; Cai S; Li N; Wu L
EBioMedicine; 2022 Sep; 83():104222. PubMed ID: 35973389
[TBL] [Abstract][Full Text] [Related]
32. Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes.
Nuzzo PV; Berchuck JE; Korthauer K; Spisak S; Nassar AH; Abou Alaiwi S; Chakravarthy A; Shen SY; Bakouny Z; Boccardo F; Steinharter J; Bouchard G; Curran CR; Pan W; Baca SC; Seo JH; Lee GM; Michaelson MD; Chang SL; Waikar SS; Sonpavde G; Irizarry RA; Pomerantz M; De Carvalho DD; Choueiri TK; Freedman ML
Nat Med; 2020 Jul; 26(7):1041-1043. PubMed ID: 32572266
[TBL] [Abstract][Full Text] [Related]
33. Genome-Wide Plasma Cell-Free DNA Methylation Profiling Identifies Potential Biomarkers for Lung Cancer.
Xu W; Lu J; Zhao Q; Wu J; Sun J; Han B; Zhao X; Kang Y
Dis Markers; 2019; 2019():4108474. PubMed ID: 30867848
[TBL] [Abstract][Full Text] [Related]
34. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA.
Liu MC; Oxnard GR; Klein EA; Swanton C; Seiden MV;
Ann Oncol; 2020 Jun; 31(6):745-759. PubMed ID: 33506766
[TBL] [Abstract][Full Text] [Related]
35. Nanopore sequencing reveals methylation changes associated with obesity in circulating cell-free DNA from Göttingen Minipigs.
Drag MH; Debes KP; Franck CS; Flethøj M; Lyhne MK; Møller JE; Ludvigsen TP; Jespersen T; Olsen LH; Kilpeläinen TO
Epigenetics; 2023 Dec; 18(1):2199374. PubMed ID: 37032646
[TBL] [Abstract][Full Text] [Related]
36. Genome-wide analysis of cell-Free DNA methylation profiling with MeDIP-seq identified potential biomarkers for colorectal cancer.
Zhang X; Li T; Niu Q; Qin CJ; Zhang M; Wu GM; Li HZ; Li Y; Wang C; Du WF; Wang CY; Zhao Q; Zhao XD; Wang XL; Zhu JB
World J Surg Oncol; 2022 Jan; 20(1):21. PubMed ID: 35065650
[TBL] [Abstract][Full Text] [Related]
37. Longitudinal monitoring of cell-free DNA methylation in ALK-positive non-small cell lung cancer patients.
Janke F; Angeles AK; Riediger AL; Bauer S; Reck M; Stenzinger A; Schneider MA; Muley T; Thomas M; Christopoulos P; Sültmann H
Clin Epigenetics; 2022 Dec; 14(1):163. PubMed ID: 36461127
[TBL] [Abstract][Full Text] [Related]
38. A method for early diagnosis of lung cancer from tumor originated DNA fragments using plasma cfDNA methylome and fragmentome profiles.
Kim YJ; Jeon H; Jeon S; Lee SH; Kim C; Ahn JH; Um H; Woo YJ; Jeong SH; Kim Y; Park HY; Oh HJ; Cho HJ; Bae JH; Kim JH; An S; Kang SB; Jho S; Biro O; Kis D; Kim BC; Kim Y; Kim JH; Kim BC; Bhak J; Oh IJ
Mol Cell Probes; 2022 Dec; 66():101873. PubMed ID: 36379302
[TBL] [Abstract][Full Text] [Related]
39. Analysis of genome-wide in cell free DNA methylation: progress and prospect.
Liu Z; Wang Z; Jia E; Ouyang T; Pan M; Lu J; Ge Q; Bai Y
Analyst; 2019 Oct; 144(20):5912-5922. PubMed ID: 31436778
[TBL] [Abstract][Full Text] [Related]
40. Genome-wide and size-based cell-free DNA indices as predictive biomarkers for locally advanced esophageal squamous cell carcinoma treated with preoperative or definitive chemoradiotherapy.
Kim EJ; Im HS; Lee J; Cho EH; Kim YH; Kim HR; Kim JH; Park SR
Curr Probl Cancer; 2021 Jun; 45(3):100685. PubMed ID: 33342577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
